Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

American Association for the Advancement of Science (AAAS) - Tập 331 Số 6024 - Trang 1565-1570 - 2011
Robert D. Schreiber1, Lloyd J. Old2, Mark J. Smyth3,4
1Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
2New York Branch of The Ludwig Institute for Cancer Research at Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
3Cancer Immunology Program, Peter MacCallum Cancer Centre, East Melbourne, 3002, Victoria, Australia
4Department of Pathology, University of Melbourne, Parkville, 3010, Victoria, Australia

Tóm tắt

Understanding how the immune system affects cancer development and progression has been one of the most challenging questions in immunology. Research over the past two decades has helped explain why the answer to this question has evaded us for so long. We now appreciate that the immune system plays a dual role in cancer: It can not only suppress tumor growth by destroying cancer cells or inhibiting their outgrowth but also promote tumor progression either by selecting for tumor cells that are more fit to survive in an immunocompetent host or by establishing conditions within the tumor microenvironment that facilitate tumor outgrowth. Here, we discuss a unifying conceptual framework called “cancer immunoediting,” which integrates the immune system’s dual host-protective and tumor-promoting roles.

Từ khóa


Tài liệu tham khảo

Ehrlich P., Ueber den jetzigen stand der Karzinomforschung. Ned. Tijdschr. Geneeskd. 5, 273 (1909).

10.1146/annurev.me.15.020164.001123

10.1136/bmj.1.5023.841

L. Thomas Cellular and Humoral Aspects of the Hypersensitive States H. Lawrence Ed. (Hoeber-Harper New York 1959).

10.1126/science.183.4124.534

10.1016/S0065-230X(08)60179-7

10.1146/annurev.iy.12.040194.005015

10.1146/annurev.immunol.21.120601.141135

10.1016/S0140-6736(00)04046-0

10.1038/nrc780

10.1016/1074-7613(94)90087-6

10.1073/pnas.95.13.7556

10.1038/35074122

10.1084/jem.192.5.755

10.1084/jem.191.4.661

10.1084/jem.20020063

10.1126/science.1063916

10.1146/annurev-immunol-031210-101324

Old L. J., Cancer immunology: The search for specificity—G. H. A. Clowes Memorial lecture. Cancer Res. 41, 361 (1981).7004632

10.1073/pnas.81.11.3511

10.1126/science.1840703

10.1073/pnas.92.25.11810

10.1158/1078-0432.CCR-09-0737

10.1038/ni1102-991

10.1016/j.immuni.2004.07.017

10.1146/annurev.immunol.22.012703.104803

10.1038/nri1961

10.1016/S0065-2776(06)90001-7

10.1172/JCI31405

10.1146/annurev.immunol.021908.132603

10.1016/j.immuni.2008.02.016

10.1038/nrc2256

Farrar J. D., et al.., Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-γ in establishing and maintaining the tumor-dormant state. J. Immunol. 162, 2842 (1999).10072532

10.1038/nature06309

10.1084/jem.20061699

10.1172/JCI42002

10.1038/nri1936

10.1038/ni1102-999

10.4049/jimmunol.164.5.2619

10.1038/nature07201

10.1016/j.cell.2010.01.025

10.1016/j.coi.2007.02.001

10.1073/pnas.1003251107

10.1126/science.1140485

10.1126/science.1140488

10.1073/pnas.0708594105

10.1158/0008-5472.CAN-06-2956

10.1038/nm1622

10.1038/nm1523

10.1038/nm.2028

10.1016/j.devcel.2010.05.014

10.1038/nature09666

10.1093/jnci/81.24.1893

10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5

Naito Y., et al.., CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58, 3491 (1998).9721846

10.1073/pnas.0509182102

10.1002/ijc.23543

10.1056/NEJMoa051424

10.1126/science.1129139

10.1146/annurev.immunol.021908.132544

10.1038/nrc1255

10.1038/3315

10.1097/00007890-200208150-00011

10.1056/NEJM200302063480620

Yuan J., et al.., Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy. Cancer Immun. 10, 1 (2010).20052966

10.1016/j.ccr.2010.11.011

10.1016/j.ccr.2010.10.002

10.1016/S0065-2776(06)90008-X

10.1056/NEJMoa1003466

10.1016/S0092-8674(00)81683-9